Microbial Regulation of Host Physiology by Short-chain Fatty Acids.
By B. van der Hee, J. Wells. Trends in Microbiology, 2021
806 citations recorded by the source corpus.
Our ancestral diet consisted of much more nondigestible fiber than that of many societies today. Thus, from an evolutionary perspective the human genome and its physiological and nutritional requirements are not well aligned to modern dietary habits. Fiber reaching the colon is anaerobically fermented by the gut bacteria, which produce short-chain fatty acids (SCFAs) as metabolic by-products. SCFAs play a role in intestinal homeostasis, helping to explain why changes in the microbiota can contribute to the pathophysiology of human diseases. Recent research has shown that SCFAs can also have effects on tissues and organs beyond the gut, through their circulation in the blood. SCFAs not only signal through binding to cognate G-protein-coupled receptors on endocrine and immune cells in the body but also induce epigenetic changes in the genome through effects on the activity of histone acetylase and histone deacetylase enzymes. Furthermore, epigenetic imprinting likely occurs in utero, highlighting the importance of the maternal diet in early life. Here we review current understanding of how SCFAs impact on human and animal physiology and discuss the potential applications of SCFAs in the prevention and treatment of human diseases.
Subfields: Food Science, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/bf6f39b74422e2ad360efd0535e87099d8c5c34a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Food Science
In Molecular Biology
In Physiology
Citations in the corpus
- Short chain fatty acids: Microbial metabolites for gut-brain axis signalling. (2022, background): “…pathway comprising the immune system, tryptophan metabolism, vagus nerve activity, the enteric nervous system (Soret et al., 2010), as well as bioactives (microbial by-products or metabolites) produced by the gut microbiome (Vuong et al., 2017; van der Hee and Wells, 2021; Fung et al., 2017).”